Boston Scientific (FRA:BSX) Interest Expense : €-250 Mil (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Boston Scientific's interest expense for the three months ended in Dec. 2023 was € -60 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-250 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Boston Scientific's Operating Income for the three months ended in Dec. 2023 was € 566 Mil. Boston Scientific's Interest Expense for the three months ended in Dec. 2023 was € -60 Mil. Boston Scientific's Interest Coverage for the quarter that ended in Dec. 2023 was 9.49. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Boston Scientific Interest Expense Historical Data

The historical data trend for Boston Scientific's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Interest Expense Chart

Boston Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-425.70

-296.74

-301.79

-443.68

-243.01

Boston Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-60.71	-64.61	-61.84	-59.61	-63.48

Boston Scientific Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-250 Mil.

Boston Scientific (FRA:BSX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Boston Scientific's Interest Expense for the three months ended in Dec. 2023 was €-60 Mil. Its Operating Income for the three months ended in Dec. 2023 was €566 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was €8,217 Mil.

Boston Scientific's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	565.789	/	-59.605
	=	9.49

The higher the ratio, the stronger the company's financial strength is.

Boston Scientific (FRA:BSX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (FRA:BSX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BSX:USA BSX:Mexico 1BSX:Italy B1SX34:Brazil BSXC:Austria

Address

300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234

Website

https://www.bostonscientific.com

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.